Performance
Stock factor profile
HALEOSLABS
HALEOSLABS · Healthcare · Pharmaceuticals & Biotechnology
SMS Lifesciences India Ltd. engages in manufacturing and selling of active pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2017-08-17. The firm's products include Ranitidine HCL (Form-2) USP / Ph.Eur, Famotidine USP / Ph. Eur / JP, Itraconazole USP / Ph.Eur / JP, Lanoconazole USP / JP and Sildenafil Citrate USP / Ph.Eur. The firm's manufacturing facilities are located at Kazipally and Jeedimetla, Hyderabad. The firm's wholly owned subsidiary is Mahi Drugs Private limited.
Last price₹1482.10
1 day+0.05%
1 month-6.73%
Model ratingLocked
Data as of04 Sep 2026
Equity review factors
Factor profile
Factor scores are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags and screen results for HALEOSLABS are part of the Wright portfolio review.
Run your free portfolio reviewFundamental snapshot
Fundamentals at a glance
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.
